SCHEMBL7141508

SCHEMBL7141508

C=CCOc1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1I

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
HCAR3 P49019 1/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144299 0.85 TDP1 (0.40) ALDH1A1NPC1RAB9ACYP1A2CYP2C9
SCHEMBL7698485 0.85 MEN1 (0.40) ALDH1A1NPC1RAB9ACYP1A2CYP2C9
SCHEMBL7141800 0.84 NPC1 (0.41) ALDH1A1KDM4ENPC1RAB9ACYP1A2
SCHEMBL7147448 0.84 NPC1 (0.39) ALDH1A1KDM4ENPC1RAB9ACYP1A2
SCHEMBL6166451 0.84 CYP1A2 (0.37) ALDH1A1NPC1RAB9ACYP1A2CYP2C9
SCHEMBL7141612 0.83 PKM (0.43) ALDH1A1MMP1MMP2MMP9MMP8
SCHEMBL7145419 0.83 MMP1 (0.39) ALDH1A1NPC1RAB9ACYP1A2MMP1
SCHEMBL7147417 0.83 NPC1 (0.36) ALDH1A1NPC1RAB9ACYP1A2CYP2C9
SCHEMBL7146610 0.81 L3MBTL1 (0.41) L3MBTL1NPC1RAB9ACYP1A2CYP2C9
SCHEMBL7141773 0.81 ALDH1A1 (0.42) ALDH1A1KDM4ENPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed